ShareValue scores for 003520.KO: Valuation 31, Quality 24, Growth 52, Health 34.

003520.KO
KRX

Yungjin Pharm Co Ltd

₩1,227.00(+0.57%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-10% to 11%
Valuation
31
Overvalued
Price vs Value
Quality
24
Weak
Business Strength
Growth
52
Moderate
Revenue & Earnings
Health
34
Stressed
Financial Stability
Momentum
31
Bearish
Price Trend

Company Details

About

Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. The company offers cephalosporin antibiotic, antipsychotic, cardiovascular, gastrointestinal, metabolic, neuropsychiatry, respiratory, infectious, anti-inflammatory and analgesics, nutritional supplement, and urology products. It also provides vitamins, minerals, and other products; and APIs. The company was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. operates as a subsidiary of KT&G Corporation.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026